Compounds > phenylpropanolamine
Page last updated: 2024-08-16

phenylpropanolamine and Urinary Retention

phenylpropanolamine has been researched along with Urinary Retention in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuo, HC; Kuo, YC; Liao, CH1
Blauwet, MB; Chapple, CR; Huang, M; Kaplan, SA; Khullar, V; Mitcheson, D; Siddiqui, E1
Bavendam, T; Guan, Z; Jones, JS; Kaplan, SA; Roehrborn, CG; Wang, JT1
Chang, HC; Chiu, B; Chung, SD; Kuo, HC; Liao, CH1
Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D1
Blaakaer, J; Høye, K; Mattiasson, A; Wein, AJ1
Araño, P; Bosch, JL; Chapple, CR; De Ridder, D; Kramer, AE; Ridder, AM1
Kaplan, SA; Te, AE; Walmsley, K1

Trials

6 trial(s) available for phenylpropanolamine and Urinary Retention

ArticleYear
Predictors of successful first-line antimuscarinic monotherapy in men with enlarged prostate and predominant storage symptoms.
    Urology, 2013, Volume: 81, Issue:5

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Endosonography; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Retention

2013
Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:10

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention; Urinary Tract Infections; Urination; Xerostomia

2014
The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.
    Neurourology and urodynamics, 2011, Volume: 30, Issue:4

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; International Cooperation; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention

2011
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
    European urology, 2013, Volume: 63, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia

2013
Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder.
    BJU international, 2003, Volume: 91, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention

2003
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
    BJU international, 2004, Volume: 93, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention; Urination

2004

Other Studies

2 other study(ies) available for phenylpropanolamine and Urinary Retention

ArticleYear
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Drug Therapy, Combination; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention

2009
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
    The Journal of urology, 2005, Volume: 174, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Incidence; Male; Middle Aged; Muscarinic Antagonists; Penile Erection; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Retention; Urination

2005